Abstract
The safety, immunogenicity, and immunologic priming of 2 dosages (2 mu g or 10 mu g) of a meningococcal C oligosaccharide-CRM197 conjugate vaccine was evaluated in 114 infants vaccinated at ages 2, 3, and 4 months. Antibody persistence and response to boosting with 10 ag Of meningococcal C polysaccharide were assessed. The meningococcal conjugate vaccine produced fewer local reactions than concurrent routine immunizations. Total serogroup C-specific immunoglobulin geometric mean concentration (GMC) increased from 0.3 mu g/mL before vaccination to 13.1 mu g/mL at age 5 months. Serum bactericidal antibody (SBA) geometric mean titers (GMTs) rose from
Original language | English |
---|---|
Pages (from-to) | 1569-1572 |
Journal | Journal of Infectious Diseases |
Volume | 179 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1999 |